NDC 50090-4177
TOUJEO Max
Insulin Glargine
TOUJEO Max is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Insulin Glargine.
| Product ID | 50090-4177_2f5dfb10-9b0d-4e2b-9c14-1ae09d148bf4 |
| NDC | 50090-4177 |
| Product Type | Human Prescription Drug |
| Proprietary Name | TOUJEO Max |
| Generic Name | Insulin Glargine |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2015-02-15 |
| Marketing Category | NDA / NDA |
| Application Number | NDA206538 |
| Labeler Name | A-S Medication Solutions |
| Substance Name | INSULIN GLARGINE |
| Active Ingredient Strength | 300 U/mL |
| Pharm Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |